Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -46.28MEnterprise Value
VS
Market
Sector
Industry
History
$ 4.76Close
$ 2.27 - $ 23.23 52-Week Range
Ticker Information
Ticker
KLRSCompany Name
KALARIS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKALARIS THERAPEUTICS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KLRS - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 88.93M | $ 0 | $ -46.28M | $ 42.64M |
| 3/31/2025 | $ 101.47M | $ 0 | $ -38.25M | $ 63.21M |
| 12/31/2024 | $ 118.29M | $ 0 | $ -68.51M | $ 49.78M |
| 9/30/2024 | $ 116.86M | $ 0 | $ -54.3M | $ 62.56M |
| 6/30/2024 | $ 105.3M | $ 9M | $ -12.6M | $ 83.7M |
| 3/31/2024 | $ 86.59M | $ 18.34M | $ 18.01M | $ 86.26M |
| 12/31/2023 | $ 90.97M | $ 27.43M | $ 25.93M | $ 89.47M |
| 9/30/2023 | $ 96.48M | $ 32.89M | $ 136.02M | $ 199.61M |
| 6/30/2023 | $ 197.81M | $ 31.5M | $ 173.02M | $ 339.33M |
| 3/31/2023 | $ 116.55M | $ 33.82M | $ 315.96M | $ 398.68M |
Key Performance Insights, Last 5 Years
- KALARIS THERAPEUTICS INC's latest trailing twelve months (TTM) EV stands at $ 1.75B.
- Over the past 5 years, KALARIS THERAPEUTICS INC's average EV has been $ 545.55M.
- The median EV for KALARIS THERAPEUTICS INC during this period was $ 279.94M
- KALARIS THERAPEUTICS INC reached its highest EV over the past 5 years at $ 2.68B.
- The lowest EV recorded by KALARIS THERAPEUTICS INC in the same timeframe $ -68.51M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for KALARIS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.88B ] + Debt [ $ 9.47M ] - CashnEq [ $ 142.25M ]
(=) EV [ $ 1.75B ] KLRS - Enterprise Value, Last 5 years
$ -68.51M
Minimum
Dec 31, 2024
$ 2.68B
Maximum
Dec 31, 2020
$ 545.55M
Average
$ 279.94M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |